John D. Sutherland

John D. Sutherland

Auto-generated profile, based on publicly available information

John D. Sutherland

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, United Kingdom

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2015 in Nature Chemistry
Verified
Journal Article
Open access
PDF file
BPBhavesh H. Patel
Bhavesh H. Patel
CPClaudia Percivalle
Claudia Percivalle
DRDougal J. Ritson
Dougal J. Ritson
CDColm D. Duffy
Colm D. Duffy
JSJohn D. Sutherland
John D. Sutherland
A minimal cell can be thought of as comprising informational, compartment-forming and metabolic subsystems. To imagine the abiotic assembly of such an overall system, however, places great demands on hypothetical prebiotic chemistry. The perceived differences and incompatibilities between these subsystems have led to the widely held assumption that one or other subsystem must have preceded the others. Here we experimentally investigate the validity of this assumption by examining the assembly of various biomolecular building blocks from prebiotically plausible intermediates and one-carbon feedstock molecules. We show that precursors of ribonucleotides, amino acids and lipids can all be derived by the reductive homologation of hydrogen cyanide and some of its derivatives, and thus that all the cellular subsystems could have arisen simultaneously through common chemistry. The key reaction steps are driven by ultraviolet light, use hydrogen sulfide as the reductant and can be accelerated by Cu(I)–Cu(II) photoredox cycling.

29 October 2015 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
JSJohn D. Sutherland
John D. Sutherland

30 September 2012 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
DRDougal Ritson
Dougal Ritson
JSJohn D. Sutherland
John D. Sutherland

7 February 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
DSDimitar D. Sasselov
Dimitar D. Sasselov
JGJohn P. Grotzinger
John P. Grotzinger
JSJohn D. Sutherland
John D. Sutherland
Comparative planetary evolution for Earth, Mars, and exoplanets holds the key to uncovering the chemistry-to-life transition.

3 June 2020 in Nature
Verified
Journal Article
Closed access
PDF file
JXJianfeng Xu
Jianfeng Xu
VCVáclav Chmela
Václav Chmela
NGNicholas J Green
Nicholas J Green
DRDavid A. Russell
David A. Russell
MJMikołaj J. Janicki
Mikołaj J. Janicki
JSJohn D. Sutherland
John D. Sutherland

16 February 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
KNKaterina Naydenova
Katerina Naydenova
KMKyle W. Muir
Kyle W. Muir
LWLong-Fei Wu
Long-Fei Wu
ZZZiguo Zhang
Ziguo Zhang
FCFrancesca Coscia
Francesca Coscia
CRChristopher J. Russo
Christopher J. Russo
Significance: While the current COVID-19 pandemic continues, the US Food and Drug Administration (FDA) has approved only one drug against the virus—remdesivir. It is a nucleotide analogue inhibitor of the SARS-CoV-2 RNA-dependent RNA polymerase; favipiravir is another member of the same class. These nucleoside analogs were originally developed against other viral polymerases, and can be quickly repurposed against SARS-CoV-2 should they prove efficacious. We used cryoEM to visualize how favipiravir-RTP binds to the replicating SARS-CoV-2 polymerase and determine how it slows RNA replication. This structure explains the mechanism of action, and will help guide the design of more potent drugs targeting SARS-CoV-2.